Tissue sealants serve primarily as a physical barrier to prevent leakage of fluid and/or gas from a surgical incision. Tissue sealants can be used to hold the flaps of internal organs together, to seal the blood vessels in case of injury/surgery or as an adjunct with hemostatic agents. These products are used to seal tissue and prevent leaks (blood, CSF, air, bile).
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Tissue Sealants under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Tissue Sealants and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Tissue Sealants under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Advanced Medical Solutions Group plc
- Aleo BME Inc
- Angiotech Pharmaceuticals Inc
- Arch Therapeutics Inc
- Arizona State University
- Baxter International Inc
- Biomedica Management Corp
- Boston University
- Calmare Therapeutics Inc
- Clemson University
- Cohera Medical Inc
- Covalent Medical, Inc. (Inactive)
- CR Bard Inc
- Department of Biomedical Engineering Columbia University
- DSM Biomedical BV
- Elastagen Pty Ltd
- Empa
- Ethicon Endo-Surgery Inc
- Gamma Diagnostics Inc
- GATT Technologies BV
- Hemostasis LLC
- HyperBranch Medical Technology Inc
- Institute of Molecular Biology of Parana
- InVivo Therapeutics Corp
- Johns Hopkins University
- Kollodis BioSciences Inc
- Kuros Biosciences AG
- Laser Tissue Welding, Inc.
- Medisse BV (Inactive)
- Meril Life Sciences Pvt Ltd
- Nurami Medical Ltd
- Pharming Group NV
- Polyganics BV
- Protein Polymer Technologies Inc (Inactive)
- Purdue University
- Samyang Biopharmaceuticals Corp
- SCL Science Inc
- Sea Run Holdings Inc
- Sealantis Ltd.
- Sealonix Inc
- Selio Medical
- Shanghai Haohai Biological Technology Co Ltd
- Surgical Sealants, Inc.
- Teijin Pharma Ltd
- Terasaki Institute for Biomedical Innovation
- Tetratherix Pty Ltd
- Texas A&M Engineering Experiment Station
- Texas A&M University
- The Medicines Co
- Tissium SA
- University of Akron